Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

PURPOSE: The status of dupilumab self-injection at home is not well understood. We therefore aimed to identify the barriers to adherence to dupilumab self-injection. PATIENTS AND METHODS: This non-interventional open-label study was conducted between March 2021 and July 2021. Patients with atopic de...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosoya, Kei, Komachi, Taro, Masaki, Katsunori, Suzaki, Isao, Saeki, Hidehisa, Kanda, Naoko, Nozaki, Makoto, Kamide, Yosuke, Matsuwaki, Yoshinori, Kobayashi, Yoshiki, Ogino, Eriko, Osada, Shin-Ichi, Usukura, Norihiro, Kurumagawa, Toshikazu, Ninomia, Junya, Asako, Mikiya, Nakamoto, Keitaro, Yokoi, Hidenori, Ohyama, Manabu, Tanese, Keiji, Kanzaki, Sho, Fukunaga, Koichi, Ebisawa, Motohiro, Okubo, Kimihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064874/
https://www.ncbi.nlm.nih.gov/pubmed/37009430
http://dx.doi.org/10.2147/PPA.S389865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064874/
https://www.ncbi.nlm.nih.gov/pubmed/37009430
http://dx.doi.org/10.2147/PPA.S389865

Ejemplares similares